Actually, FDG6P is a recognized substrate for this enzyme whose activity explains the relatively low sensitivity of PET-FDG in hepatocellular carcinoma as the unique cancer type in which G6Pase has been described so far26. This evidence concerns the gene G6PC1 and cancer.